These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15284589)

  • 1. Outcome and prognostic factors of acute lymphoblastic leukemia in children at the National Cancer Institute, Egypt.
    Hussein H; Sidhom I; Naga SA; Amin M; Ebied E; Khairy A; Kamel A; El-Sharkawy N
    J Pediatr Hematol Oncol; 2004 Aug; 26(8):507-14. PubMed ID: 15284589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZAP-70 as a possible prognostic factor in childhood acute lymphoblastic leukemia.
    Ebeid E; Kamel M; Moussa H; Galal U
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):121-6. PubMed ID: 20029467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt - A single center experience.
    Rahman Sayed HA; Sedky M; Hamoda A; Kinaaie NE; Wakeel ME; Hesham D
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):175-81. PubMed ID: 27339800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
    Pui CH; Chessells JM; Camitta B; Baruchel A; Biondi A; Boyett JM; Carroll A; Eden OB; Evans WE; Gadner H; Harbott J; Harms DO; Harrison CJ; Harrison PL; Heerema N; Janka-Schaub G; Kamps W; Masera G; Pullen J; Raimondi SC; Richards S; Riehm H; Sallan S; Sather H; Shuster J; Silverman LB; Valsecchi MG; Vilmer E; Zhou Y; Gaynon PS; Schrappe M
    Leukemia; 2003 Apr; 17(4):700-6. PubMed ID: 12682627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
    Smith M; Arthur D; Camitta B; Carroll AJ; Crist W; Gaynon P; Gelber R; Heerema N; Korn EL; Link M; Murphy S; Pui CH; Pullen J; Reamon G; Sallan SE; Sather H; Shuster J; Simon R; Trigg M; Tubergen D; Uckun F; Ungerleider R
    J Clin Oncol; 1996 Jan; 14(1):18-24. PubMed ID: 8558195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital.
    Pui CH; Boyett JM; Rivera GK; Hancock ML; Sandlund JT; Ribeiro RC; Rubnitz JE; Behm FG; Raimondi SC; Gajjar A; Razzouk B; Campana D; Kun LE; Relling MV; Evans WE
    Leukemia; 2000 Dec; 14(12):2286-94. PubMed ID: 11187920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study.
    Uckun FM; Steinherz PG; Sather H; Trigg M; Arthur D; Tubergen D; Gaynon P; Reaman G
    Blood; 1996 Dec; 88(11):4288-95. PubMed ID: 8943865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period.
    Thomas X; Danaïla C; Le QH; Sebban C; Troncy J; Charrin C; Lhéritier V; Michallet M; Magaud JP; Fiere D
    Leukemia; 2001 Dec; 15(12):1811-22. PubMed ID: 11753600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term efficacy and prognostic factors of Beijing Children's Hospital-2009-lymphoblastic lymphoma in the treatment of T-lymphoblastic lymphoma in children and adolescents].
    Jin L; Yang J; Duan YL; Huang S; Zhang M; Zhou CJ; Zhang NN; Zhang YH
    Zhonghua Yi Xue Za Zhi; 2024 Jul; 104(29):2759-2766. PubMed ID: 39075996
    [No Abstract]   [Full Text] [Related]  

  • 14. Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
    Aricò M; Basso G; Mandelli F; Rizzari C; Colella R; Barisone E; Zanesco L; Rondelli R; Pession A; Masera G
    Cancer; 1995 Apr; 75(7):1684-93. PubMed ID: 8826928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
    Schultz KR; Pullen DJ; Sather HN; Shuster JJ; Devidas M; Borowitz MJ; Carroll AJ; Heerema NA; Rubnitz JE; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Gaynon PS; Camitta BM
    Blood; 2007 Feb; 109(3):926-35. PubMed ID: 17003380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador.
    Bonilla M; Moreno N; Marina N; deReyes G; Shurtleff SA; Downing JR; Behm FG; Harrison PL; Ribeiro RC; Peña O; Crist WM; Antillon FG
    J Pediatr Hematol Oncol; 2000; 22(6):495-501. PubMed ID: 11132215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
    Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004.
    Kamps WA; van der Pal-de Bruin KM; Veerman AJ; Fiocco M; Bierings M; Pieters R
    Leukemia; 2010 Feb; 24(2):309-19. PubMed ID: 20016528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.
    Pui CH; Pei D; Coustan-Smith E; Jeha S; Cheng C; Bowman WP; Sandlund JT; Ribeiro RC; Rubnitz JE; Inaba H; Bhojwani D; Gruber TA; Leung WH; Downing JR; Evans WE; Relling MV; Campana D
    Lancet Oncol; 2015 Apr; 16(4):465-74. PubMed ID: 25800893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.